Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883987961> ?p ?o ?g. }
- W2883987961 endingPage "6120" @default.
- W2883987961 startingPage "6110" @default.
- W2883987961 abstract "We report the structure-based discovery of CF53 (28) as a highly potent and orally active inhibitor of bromodomain and extra-terminal (BET) proteins. By the incorporation of a NH-pyrazole group into the 9H-pyrimido[4,5- b]indole core, we identified a series of compounds that bind to BRD4 BD1 protein with Ki values of <1 nM and achieve low nanomolar potencies in the cell growth inhibition of leukemia and breast cancer cells. The most-promising compound, CF53, possesses excellent oral pharmacokinetic properties and achieves significant antitumor activity in both triple-negative breast cancer and acute leukemia xenograft models in mice. Determination of the co-crystal structure of CF53 with the BRD4 BD1 protein provides a structural basis for its high binding affinity to BET proteins. CF53 is very selective over non-BET bromodomain-containing proteins. These data establish CF53 as a potent, selective, and orally active BET inhibitor, which warrants further evaluation for advanced preclinical development." @default.
- W2883987961 created "2018-08-03" @default.
- W2883987961 creator A5004075655 @default.
- W2883987961 creator A5012092064 @default.
- W2883987961 creator A5012392120 @default.
- W2883987961 creator A5021482855 @default.
- W2883987961 creator A5024364780 @default.
- W2883987961 creator A5027601671 @default.
- W2883987961 creator A5042658750 @default.
- W2883987961 creator A5046488682 @default.
- W2883987961 creator A5049458323 @default.
- W2883987961 creator A5052716698 @default.
- W2883987961 creator A5054736873 @default.
- W2883987961 creator A5056575288 @default.
- W2883987961 creator A5065338783 @default.
- W2883987961 creator A5069778809 @default.
- W2883987961 creator A5070109882 @default.
- W2883987961 creator A5070154658 @default.
- W2883987961 creator A5073754378 @default.
- W2883987961 creator A5075953023 @default.
- W2883987961 creator A5082256258 @default.
- W2883987961 creator A5085462251 @default.
- W2883987961 date "2018-07-17" @default.
- W2883987961 modified "2023-09-26" @default.
- W2883987961 title "Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor" @default.
- W2883987961 cites W1539796472 @default.
- W2883987961 cites W1969360633 @default.
- W2883987961 cites W2003872705 @default.
- W2883987961 cites W2013339218 @default.
- W2883987961 cites W2019083110 @default.
- W2883987961 cites W2024469844 @default.
- W2883987961 cites W2032365395 @default.
- W2883987961 cites W2040608136 @default.
- W2883987961 cites W2041535798 @default.
- W2883987961 cites W2048964430 @default.
- W2883987961 cites W2052692973 @default.
- W2883987961 cites W2092687362 @default.
- W2883987961 cites W2097493124 @default.
- W2883987961 cites W2107911443 @default.
- W2883987961 cites W2123647733 @default.
- W2883987961 cites W2124026197 @default.
- W2883987961 cites W2154714625 @default.
- W2883987961 cites W2163341755 @default.
- W2883987961 cites W2232389113 @default.
- W2883987961 cites W2234034631 @default.
- W2883987961 cites W2270241120 @default.
- W2883987961 cites W2295358737 @default.
- W2883987961 cites W2298793032 @default.
- W2883987961 cites W2378228402 @default.
- W2883987961 cites W2411462408 @default.
- W2883987961 cites W2560429659 @default.
- W2883987961 cites W2566650983 @default.
- W2883987961 cites W2587935821 @default.
- W2883987961 cites W2606852909 @default.
- W2883987961 cites W2611860612 @default.
- W2883987961 cites W2760757128 @default.
- W2883987961 cites W594415895 @default.
- W2883987961 doi "https://doi.org/10.1021/acs.jmedchem.8b00483" @default.
- W2883987961 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6489120" @default.
- W2883987961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30015487" @default.
- W2883987961 hasPublicationYear "2018" @default.
- W2883987961 type Work @default.
- W2883987961 sameAs 2883987961 @default.
- W2883987961 citedByCount "26" @default.
- W2883987961 countsByYear W28839879612018 @default.
- W2883987961 countsByYear W28839879612019 @default.
- W2883987961 countsByYear W28839879612020 @default.
- W2883987961 countsByYear W28839879612021 @default.
- W2883987961 countsByYear W28839879612022 @default.
- W2883987961 countsByYear W28839879612023 @default.
- W2883987961 crossrefType "journal-article" @default.
- W2883987961 hasAuthorship W2883987961A5004075655 @default.
- W2883987961 hasAuthorship W2883987961A5012092064 @default.
- W2883987961 hasAuthorship W2883987961A5012392120 @default.
- W2883987961 hasAuthorship W2883987961A5021482855 @default.
- W2883987961 hasAuthorship W2883987961A5024364780 @default.
- W2883987961 hasAuthorship W2883987961A5027601671 @default.
- W2883987961 hasAuthorship W2883987961A5042658750 @default.
- W2883987961 hasAuthorship W2883987961A5046488682 @default.
- W2883987961 hasAuthorship W2883987961A5049458323 @default.
- W2883987961 hasAuthorship W2883987961A5052716698 @default.
- W2883987961 hasAuthorship W2883987961A5054736873 @default.
- W2883987961 hasAuthorship W2883987961A5056575288 @default.
- W2883987961 hasAuthorship W2883987961A5065338783 @default.
- W2883987961 hasAuthorship W2883987961A5069778809 @default.
- W2883987961 hasAuthorship W2883987961A5070109882 @default.
- W2883987961 hasAuthorship W2883987961A5070154658 @default.
- W2883987961 hasAuthorship W2883987961A5073754378 @default.
- W2883987961 hasAuthorship W2883987961A5075953023 @default.
- W2883987961 hasAuthorship W2883987961A5082256258 @default.
- W2883987961 hasAuthorship W2883987961A5085462251 @default.
- W2883987961 hasBestOaLocation W28839879613 @default.
- W2883987961 hasConcept C104317684 @default.
- W2883987961 hasConcept C161624437 @default.
- W2883987961 hasConcept C181389837 @default.
- W2883987961 hasConcept C185592680 @default.
- W2883987961 hasConcept C2779634854 @default.
- W2883987961 hasConcept C2780862049 @default.